Breast Cancer - MR Cancer - Department of Circulation and Medical Imaging
Breast cancer – imaging, metabolism and novel therapeutic strategies.
For most breast cancer patients, prognosis is relatively good. In Norway, more than 75% of the women are still alive more than 15 years after the time point of diagnosis. There has been a slight increase in the five-year relative survival for most cancers when comparing the five-year period (2014–2018) with the previous one from 89.3% to 90.7% (Cancer in Norway 2018, Kreftregisteret).
Nevertheless, there are still several challenges that need to be solved. Some patients have advanced disease, whereas others have particularly aggressive subtypes of breast cancer.
The objective of the CIMORe Group is to introduce advanced magnetic resonance imaging (MRI) methods into clinical practice, thereby improving diagnostic accuracy. In addition, we aim to provide a better understanding of breast cancer metabolism (which can be studied using MR spectroscopy) in order to improve risk evaluation and identify novel therapeutic strategies.
Magnetic Resonance Spectroscopy (MRS): From anatomy to biochemistry:
Contact
-
Tone Frost Bathen Professor
+47-73551355 +4795021097 tone.f.bathen@ntnu.no Department of Circulation and Medical Imaging -
Guro F. Giskeødegård Professor
+47-73598916 +4790550347 guro.giskeodegard@ntnu.no Department of Public Health and Nursing -
Siver Andreas Moestue Professor
+47-73551353 +4791111174 siver.a.moestue@ntnu.no Department of Clinical and Molecular Medicine
